Immunohistochemical expressions of adropin and ınducible nitric oxide synthase in renal tissues of rats with streptozotocin-ınduced experimental diabetes

References

• Alderton WK, Angell AD, Craig C, Dawson J, Garvey E, Moncada S, Monkhouse J, Rees D, Russell LJ, Russell RJ, Schwartz S, Waslidge N, Knowles RG (2005). GW274150 and GW273629 are potent and highly selective inhibitors of inducible nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol. 145: 301–312.
   PubMed Web of Science ®Google Scholar
• Barner C, Petersson M, Edén Engström B, Höybye C (2012). Effects on insulin sensitivity and body composition of combination therapy with GH and IGF1 in GH deficient adults with type 2 diabetes. Eur. J. Endocrinol. 167: 697–703.
   PubMed Web of Science ®Google Scholar
• Catalina PF, Andrade MA, García-Mayor RV, Mallo F (2002). Altered GH elimination kinetics in type 1 diabetes mellitus can explain the elevation in circulating levels: bicompartmental approach. J. Clin. Endocrinol. Metab. 87: 1785–1790.
   PubMed Web of Science ®Google Scholar
• Celik A, Balin M, Kobat MA, Erdem K, Baydas A, Bulut M, Altas Y, Aydin S, Aydin S (2013a). Deficiency of a New Protein Associated with Cardiac Syndrome X; Called Adropin. Cardiovasc. Ther. 31: 174–8.
   PubMed Web of Science ®Google Scholar
• Celik E, Yilmaz E, Celik O, Ulas M, Turkcuoglu I, Karaer A, Simsek Y, Minareci Y, Aydin S (2013b). Maternal and fetal adropin levels in gestational diabetes mellitus. J. Perinat. Med. 9: 1–6.
   Google Scholar
• Cho WC, Yip TT, Chung WS, Leung AW, Cheng CH, Yue KK (2006). Differential expression of proteins in kidney, eye, aorta, and serum of diabetic and non-diabetic rats. J. Cell. Biochem. 99: 256–268.
   PubMed Web of Science ®Google Scholar
• Clevers HC, Bevins CL (2013). Paneth cells: maestros of the small intestinal crypts. Ann. Rev. Physiol. 75: 289–311.
   PubMed Web of Science ®Google Scholar
• Cunliffe RN, Rose FR, Keyte J, Abberley L, Chan WC, Mahida YR (2001). Human defensin 5 is stored in precursor form in normal Paneth cells and is expressed by some villous epithelial cells and by metaplastic Paneth cells in the colon in inflammatory bowel disease. Gut 48: 176–185.
   PubMed Web of Science ®Google Scholar
• Dagli AF, Aydin S, Karaoglu A, Akpolat N, Ozercan IH, Ozercan MR (2009). Ghrelin expression in normal kidney tissue and renal carcinomas. Pathol. Res. Pract. 205: 165–173.
   PubMed Web of Science ®Google Scholar
• Desouza CV, Hamel FG, Bidasee K, O’Connell K (2011). Role of inflammation and insulin resistance in endothelial progenitor cell dysfunction. Diabetes 60: 1286–1294.
   PubMed Web of Science ®Google Scholar
• Flier JS (2012). Hormone resistance in diabetes and obesity: insulin, leptin, and FGF21. Yale J. Biol. Med. 85: 405–414.
   PubMedGoogle Scholar
• Ganesh Kumar K, Zhang J, Gao S, Rossi J, McGuinness OP, Halem HH, Culler MD, Mynatt RL, Butler AA (2012). Adropin deficiency is associated with increased adiposity and insulin resistance. Obesity (Silver Spring) 20: 1394–1402.
   PubMed Web of Science ®Google Scholar
• Gross GJ, Hsu A, Pfeiffer AW, Nithipatikom K (2013). Roles of endothelial nitric oxide synthase (eNOS) and mitochondrial permeability transition pore (MPTP) in epoxyeicosatrienoic acid (EET)-induced cardioprotection against infarction in intact rat hearts. J. Mol. Cell Cardiol. 59: 20–9.
   PubMed Web of Science ®Google Scholar
• Gutierrez JC, Bahamonde J, Prater MR, Yefi CP, Holladay SD (2010). Production of a type 2 maternal diabetes rodent model using the combination of high-fat diet and moderate dose of streptozocin. Endocr. Res. 35: 59–70.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Ben Q, Shen H, Lu W, Zhang Y, Zhu J (2011). Diabetes mellitus and incidence and mortality of colorectal cancer: a systematic review and meta-analysis of cohort studies. Eur. J. Epidemiol. 26: 863–876.
   PubMed Web of Science ®Google Scholar
• Knowles RG, Moncada S (1994). Nitric oxide synthases in mammals. Biochem. J. 298: 249–258.
   PubMed Web of Science ®Google Scholar
• Kuloglu T, Dabak DO (2009). Determination of ghrelin immunoreactivity in kidney tissues of diabetic rats. Renal Fail. 31: 562–566.
   PubMed Web of Science ®Google Scholar
• Kumar KG, Trevaskis JL, Lam DD, Sutton GM, Koza RA, Chouljenko VN, Kousoulas KG, Rogers PM, Kesterson RA, Thearle M, Ferrante AW Jr, Mynatt RL, Burris TP, Dong JZ, Halem HA, Culler MD, Heisler LK, Stephens JM, Butler AA (2008). Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell Metab. 8: 468–481.
   PubMed Web of Science ®Google Scholar
• Lian W, Gu X, Qin Y, Zheng X (2011). Elevated plasma levels of adropin in heart failure patients. Intern. Med. 50: 1523–1527.
   PubMed Web of Science ®Google Scholar
• Lin CC, Lin LT, Yen MH, Cheng JT, Hsing CH, Yeh CH (2012). Renal protective effect of xiao-chai-hu-tang on diabetic nephropathy of type 1-diabetic mice. Evidence Based Complement Alt. Med. 2012: 984024.
   PubMed Web of Science ®Google Scholar
• Lovren F, Pan Y, Quan A, Singh KK, Shukla PC, Gupta M, Al-Omran M, Teoh H, Verma S (2010). Adropin is a novel regulator of endothelial function. Circulation 122: S185–S192.
   PubMed Web of Science ®Google Scholar
• Martin-Gronert MS, Ozanne SE (2012). Metabolic programming of insulin action and secretion. Diabetes Obes. Metab. 14: 29–39.
   PubMed Web of Science ®Google Scholar
• Nordquist L, Liss P, Fasching A, Hansell P, Palm F (2013). Hypoxia in the diabetic kidney is independent of advanced glycation end-products. Adv. Exp. Med. Biol. 765: 185–193.
   PubMed Web of Science ®Google Scholar
• Quattrini C, Jeziorska M, Boulton AJ, Malik RA (2008). Reduced vascular endothelial growth factor expression and intra-epidermal nerve fiber loss in human diabetic neuropathy. Diabetes Care 31: 140–145.
   PubMed Web of Science ®Google Scholar
• Robles NR, Ferreira F, Martinez-Gallardo R, Alvarez Gregori J, Sanchez-Casado E, Cubero JJ, Macias J (2012). Hematocrit, urea and gender: the hematocrit, urea and gender formula for prognosing progressive renal failure in diabetic nephropathy. Eur. J. Intern. Med. 23: 283–286.
   PubMed Web of Science ®Google Scholar
• Sahin I, Aydin S (2013). Serum concentration and kidney expression of salusin-α and salusin-β in rats with metabolic syndrome induced by fructose. Biotech. & Histochem. 88: 153–60.
   PubMed Web of Science ®Google Scholar
• Satirapoj B (2012). Nephropathy in diabetes. Adv. Exp. Med. Biol. 771: 107–122.
   PubMed Web of Science ®Google Scholar
• Sugimoto H, Shikata K, Wada J, Horiuchi S, Makino H (1999). Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-alpha and inducible nitric oxide synthase in diabetic rat glomeruli. Diabetologia 42: 878–886.
   PubMed Web of Science ®Google Scholar
• Szlachcic A, Krzysiek-Maczka G, Pajdo R, Targosz A, Magierowski M, Jasnos K, Drozdowicz D, Kwiecien S, Brzozowski T (2013). The impact of asymmetric dimethylarginine (ADAMA), the endogenous nitric oxide (NO) synthase inhibitor, to the pathogenesis of gastric mucosal damage. Curr. Pharm. Res. 19: 90–97.
   PubMed Web of Science ®Google Scholar